Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Vaxart, Inc. (VXRT)

Compare
0.3725
-0.0345
(-8.48%)
At close: April 1 at 4:00:00 PM EDT
0.3844
+0.01
+(3.19%)
After hours: April 1 at 7:55:15 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
28,700
28,700
7,379
107
892
Operating Expense
94,993
94,993
90,726
110,440
70,639
Operating Income
-66,293
-66,293
-83,347
-110,333
-69,747
Net Non Operating Interest Income Expense
-426
-426
1,205
-58
-1,399
Other Income Expense
31
31
-62
2,700
783
Pretax Income
-66,688
-66,688
-82,204
-107,691
-70,363
Tax Provision
260
260
261
67
107
Net Income Common Stockholders
-66,948
-66,948
-82,465
-107,758
-70,470
Diluted NI Available to Com Stockholders
-66,948
-66,948
-82,465
-107,758
-70,470
Basic EPS
-0.40
-0.33
-0.57
-0.84
-0.58
Diluted EPS
-0.40
-0.33
-0.57
-0.84
-0.58
Basic Average Shares
180,703.8950
202,137.5310
144,819.7810
127,683.8130
121,453.7230
Diluted Average Shares
180,703.8950
202,137.5310
144,819.7810
127,683.8130
121,453.7230
Total Operating Income as Reported
-66,293
-66,293
-83,347
-114,587
-72,752
Total Expenses
94,993
94,993
90,726
110,440
70,639
Net Income from Continuing & Discontinued Operation
-66,948
-66,948
-82,465
-107,758
-70,470
Normalized Income
-66,948
-66,948
-82,465
-104,397.3400
-68,275.6200
Interest Income
2,543
2,543
2,652
1,247
81
Interest Expense
2,969
2,969
1,447
1,305
1,480
Net Interest Income
-426
-426
1,205
-58
-1,399
EBIT
-63,719
-63,719
-80,757
-106,386
-68,883
EBITDA
-54,869
-54,869
-72,133
-100,581
-64,675
Reconciled Depreciation
8,850
8,850
8,624
5,805
4,208
Net Income from Continuing Operation Net Minority Interest
-66,948
-66,948
-82,465
-107,758
-70,470
Total Unusual Items Excluding Goodwill
-3,007
--
--
-4,254
-3,006
Total Unusual Items
-3,007
--
--
-4,254
-3,006
Normalized EBITDA
-54,869
-54,869
-72,133
-96,327
-61,669
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
--
--
--
-893.3400
-811.6200
12/31/2021 - 12/11/1981

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

INO Inovio Pharmaceuticals, Inc.
1.5000
-7.98%
 
OCGN Ocugen, Inc.
0.6472
-8.37%
 
NVAX Novavax, Inc.
6.00
-6.40%
 
IBIO iBio, Inc. Common Stock
3.9100
-2.74%
 
SRNE Sorrento Therapeutics, Inc.
0.0010
0.00%
 
JAGX Jaguar Health, Inc.
4.7600
+0.21%
 
TNXP Tonix Pharmaceuticals Holding Corp.
17.45
-2.38%
 
CVAC CureVac N.V.
2.7200
-1.81%
 
ALT Altimmune, Inc.
4.7450
-5.10%
 
VIR Vir Biotechnology, Inc.
6.18
-4.63%